Pilulka has signed a loan agreement with Growth Expert, a company controlled by TCF Capital, a group managing Tomáš Čupr's capital. The agreement allows for a loan of up to CZK 80 million. Pilulka will use the funds from the loan mainly to increase working capital and pay off suppliers' receivables.

The agreement also includes an option in favour of the lender to acquire a controlling interest in Pilulka Lékárny from certain existing shareholders on terms agreed with those shareholders. Pilulka operates its own and partner brick-and-mortar pharmacies in the Czech Republic and an online store, where, in addition to medicines and dietary supplements, it also offers cosmetics, pharmaceuticals and certain food products.

Last year, Pilulka's net loss widened by more than CZK 110 million year-on-year to CZK 175.9 million and its sales fell by about 12 percent to CZK 2.1 billion. The decline was mainly due to the costs of unsuccessful foreign expansions and the company's transformation. Pill decided to exit its business in Romania last summer and also closed its operations in Austria and Hungary towards the end of the year.

The largest shareholders of Pilulka are the founders of the Kasova brothers, pharmaceutical trader Marek Krajčovič and All-Star Holding Limited from the Wood & Company financial group.